The Mantle Cell International Prognostic Index (MIPI) is an ASSESSMENT TOOL.

The Mantle Cell International Prognostic Index is used for PATIENTS presenting with advanced stage Mantle Cell Lymphoma (MCL) to determine the prognosis and therapy to be delivered.

For further information on the Mantle Cell International Prognostic Index, see: Mantle Cell Lymphoma International Prognostic Index (MIPI).

This supporting information is also known by these names:

Context	Alias
shortname	MIPI